image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Our latest issue will be released in 6 days, don't miss out!

Tyman

June 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • TYMN
  • Price:
  • 383p
The shares soared £1 after Tyman accepted an agreed offer from larger US rival Quanex Building Products. The latter is offering 240p in cash and 0.05715 Qanex shares (or all share alternative of 0.14288 Quanex shares) valuing the group at around £4 (plus a 9.5p final dividend)  and represents a premium of 40.5% to the six-month volume weighted average price. The enlarged group will have revenues of around US$2 billion and a higher EBITDA margin after allowing for cost synergies of US$30m. It also offers a more diversified base of customers and products; strengthened brand leadership and greater opportunities in the huge US market.   Quoted on the NYSE, Quanex (NX. $34.93) has risen from around US$25 at the start of 2023 to ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X